Publications by authors named "Emily Robitschek"

Claim this Profile
A
A large language model-based approach to quantifying the effects of social determinants in liver transplant decisions.
Emily Robitschek, Asal Bastani, Kathryn Horwath, Savyon Sordean, Mark J Pletcher

NPJ Digit Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapy.
Andrew D Knight, Emily J Robitschek, Jia-Ren Lin, Dennie T Frederick, Alvin Shi

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma.
Jiekun Yang, Cassia Wang, Doris Fu, Li-Lun Ho, Kyriakitsa Galani, Emily J Robitschek

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific oncogene activation of the cell of origin in mucosal melanoma.
Swathy Babu, Jiajia Chen, Chloé S Baron, Kaiwen Sun, Emily Robitschek

Nat Commun· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.
Hsiao-Wei Tsao, Seth Anderson, Kenneth J Finn, Jonathan J Perera, Lomax F Pass, Emily J Robitschek

Immunity· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratified analysis identifies HIF-2 as a therapeutic target for highly immune-infiltrated melanomas.
Amy Y Huang, Kelly P Burke, Ryan Porter, Lynn Meiger, Peter Fatouros, Emily Robitschek

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific oncogene activation of the cell of origin in mucosal melanoma.
Swathy Babu, Jiajia Chen, Emily Robitschek, Chloé S Baron, Alicia McConnell

bioRxiv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Emily J Robitschek

Nature· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Gabriel K Griffin, Jingyi Wu, Arvin Iracheta-Vellve, James C Patti, Jeffrey Hsu, Emily J Robitschek

Nature· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of delayed resistance to immunotherapy in a melanoma responder.
David Liu, Jia-Ren Lin, Emily J Robitschek, Gyulnara G Kasumova, Alex Heyde

Nat Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
Jeffrey J Ishizuka, Robert T Manguso, Collins K Cheruiyot, Kevin Bi, Arpit Panda, Emily J Robitschek

Nature· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis